Drafting Process and key Points of ICH Q2(R2) and Q14 Guideline (2)

DOI
  • HIYAMA Yukio
    Rapporteur of ICH Q2Q14 Expert Working Group Visiting Scientist, Division of Drugs, National Institute of Health Sciences

Bibliographic Information

Other Title
  • ICH Q2(R2)，Q14ガイドラインの作成状況と論点解説─(2)

Search this article

Description

<p>This article describes the drafting process and key points of ICH Q2(R2)(Analytical Validation) and ICH Q14(Analytical Development). The harmonization effort started in 2018 and the two documents are being drafted by one Expert Working Group. The drafts for public consultation will be published in early 2022. The revised Q2 will include spectroscopic procedures, procedures used for biologics, multivariate analysis based procedures, etc. The new Q14 will cover Enhanced (Quality by Design) development approach. Q14 emphasizes that the enhanced knowledge supports robust analytical procedures and their effective lifecycle management.</p>

Journal

Keywords

Details 詳細情報について

Report a problem

Back to top